Murilo Da Silveira, ARNP

Murilo Da Silveira practices at Dispatchhealth in Denver, Colorado.

Murilo Da Silveira's NPI, 1700320959, was assigned on December 7, 2016. Murilo Da Silveira holds Florida license APRN9347540.

Murilo Da Silveira's primary practice is Dispatchhealth, at 3825 N Lafayette St, Denver, CO 80205-3316. The practice phone is (303) 500-1518.

Murilo Da Silveira's primary practice is Dispatchhealth in Denver, Colorado. The medical group on file is DispatchHealth. Dmand AI also links Murilo Da Silveira to 8 more medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Murilo Da Silveira practices, 5 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Murilo Da Silveira's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Murilo Da Silveira is licensed in Florida.

Dmand AI lists acute gastroduodenitis, acute sinusitis, acute skin infection, bronchitis, chronic diabetes, chronic kidney disease, chronic obstructive pulmonary disease (COPD) and conjunctivitis among the conditions Murilo Da Silveira treats.

CMS data shows 666 Medicare services from Murilo Da Silveira across 13 procedure codes in 2024, for 602 Medicare patients. Medicare paid $30,743 for them. Every service was in an office.

CMS counts 602 Medicare patients who saw Murilo Da Silveira in 2024. The largest group is 75 to 84, with 208 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Murilo Da Silveira's median patient age at 76, with 69% women.

In 2024, Murilo Da Silveira wrote 1,778 Medicare Part D claims for 1,167 patients. 91% of them were for generic drugs. CMS names the drug for 1,453 of them, across 33 drugs with 11 or more claims each, at $26,852 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 65 out of 100 for Murilo Da Silveira for performance year 2024, reported as part of a group. Murilo Da Silveira accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Murilo Da Silveira as offering telehealth.